Skip to main content
. 2020 Aug 18;47(11):1257–1266. doi: 10.1111/1346-8138.15514

Figure 1.

Figure 1

(a) Progression‐free survival (PFS) and (b) overall survival (OS). CI, confidence interval; IPI, ipilimumab; NIVO, nivolumab; NR, not reached.